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Abstract Immunodiagnostictestsrepresentanimportanttool
for diagnosis of cysticercosis, the disease caused by cysticerci
of Taenia solium. Accurate diagnosis of neurocysticercosis
(NCC) requires costly neuroimaging techniques (magnetic
resonance imaging and computed tomography), which are
seldom affordable for people in endemic countries. Hence,
new low-cost diagnostic methods offering good sensitivity
and specificity are needed. Here, we studied four immunodi-
agnostic tests immunodot blot Tsol-p27, a commercial
ELISA,andWesternblotTsol-p27/TsolHSP36,andcompared
them with a commercial enzyme-linked immunoelectrotrans-
fer blot (EITB) that we regarded as the gold standard method.
Theanalyzedserumsampleswereobtainedfrom160patients:
94 epileptics suspected of NCC, six individuals confirmed
NCC-positive, and 60 with positive (30) or negative (30)
serology for Chagas diseases. Of the 100 serum samples from
epileptic patients, 13 were positive and 87 negative by EITB.
Compared to Western blot Tsol-p27, immunodot blot Tsol-
p27 offered similar specificity (97.8% vs. 95.6%) but better
sensitivity (86.7% vs. 76.4%). The ELISAwas similar to the
immunodot blot Tsol-p27 regarding both sensitivity and spec-
ificity. Western blot TsolHSP36 provided the lowest sensitiv-
ity (61.9%) and specificity (86.1%). None of the antibodies in
the serum samples from the Chagas control groups were
recognized by immunodot blot Tsol-p27. Our results indicate
that the immunodot blot Tsol-p27 provides good sensitivity
and specificity. Furthermore, considering the simplicity and
low cost of this test, it might be preferable as a diagnostic
method in poorly equipped laboratories in endemic countries.
Introduction
Cysticercosis is a disease caused by larval stages (metacest-
odes) of Taenia solium, which is considered a public health
problem in many low-income countries in Latin America,
Africa, and Asia. Notably, this illness is now also emerging
in some high-income nations as the result of travel to or
immigration from endemic areas (Mahanty and Garcia
2010; Sciutto et al. 2000). Cysticercosis develops after
accidental ingestion of T. solium eggs passed in the feces
of human hosts harboring the adult stage of the parasite in
their intestines. Once inside a human, the oncospheres hatch
and penetrate the intestinal wall, and subsequently invade
various tissues, where they encyst to form cysticerci (Flisser
1994; Raether and Hanel 2003). The main clinical manifes-
tation of the infection is neurocysticercosis (NCC), which
occurs when cysticerci are established in the tissues of the
brain and central nervous system (Garcia et al. 2002). The
clinical signs and symptoms of NCC are inconsistent and
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blindness, epilepsy, and various neurological symptoms
(Del Brutto 2005). NCC is a major cause of adult-onset
epilepsy in areas where T. solium is prevalent (Flisser
1994). Moreover, in endemics countries, T. solium has been
identified as the primary etiological agent of epileptic seiz-
ures, accounting for 30–50% of all cases of late-onset epi-
lepsy (Lescano et al. 2009).
Diagnosis of NCC is complicated because of the unspe-
cific clinical manifestation of this disease. Accurate diagno-
sis can be achieved by use of neuroimaging methods such as
magnetic resonance imaging (MRI) and computed tomog-
raphy (CT), followed by a confirmatory serological test
(Carpio et al. 1998). Unfortunately, in countries where T.
solium is endemic, radio-imaging methods are seldom af-
fordable and therefore inaccessible to the population at risk
(Diaz et al. 1992). The laboratory diagnosis of cysticercosis
is based on serological detection of antibodies against cys-
ticerci (Deckers and Dorny 2010). Enzyme-linked immuno-
assay (ELISA) and enzyme-linked immunoelectrotransfer
blot (EITB) are the most frequently used immunodiagnostic
tests for human cysticercosis (Dorny et al. 2003); both those
methods are specific and sensitive, but they also have the
disadvantage of requiring expensive, specialized equipment
that must be run by skilled technicians (Deckers and Dorny
2010; Tsang et al. 1989). Thus, there is a continuing need
for alternative diagnostic methods that are practical, repro-
ducible, and economical, and also reduce the use of crude
material (Deckers and Dorny 2010; Lundstrom et al. 2010;
Salazar-Anton and Lindh 2011). Applying recombinant
DNA technology can generate antigenic proteins that can
serve as simplified, low-cost substitutes for native antigens.
As an example of this, the recombinant form of the Tsol-p27
protein identified in T. solium cysticerus might prove useful
as a target for diagnostic tools (Salazar-Anton and Lindh
2011). Our aim here was to compare results obtained with
an immunodot blot assay based on the Tsol-p27 protein and
different immunodiaganostic formats and antigens, using an




A total of 100 human serum samples were collected from
epileptic patients who attended the health centers of the
Departments of Chinandega and Rosita in Nicaragua be-
tween March and August 2010.The inclusion criteria for
epileptic patients were based on clinical signs, symptoms
(including seizure unrelated to withdrawal of drugs or
alcohol), physical examination, epidemiologic information,
and other associated risk factors.
In addition, 60 serum samples with positive (30 sera) or
negative(30sera)indirectimmunofluorescence(IF)serologyfor
C h a g a sd i s e a s ew e r ei n c l u d e d .A l ls e r aw e r es t o r e da t−20°C
until used. The study protocol was approved by the Ethics
Committee of the Faculty of Medical Science at the National
Autonomous University of Nicaragua-León (UNAN-León).
Expression and purification of recombinant Tsol-p27 and
TsolHSP36 proteins
The process of cloning the Tsol-p27 and TsolHSP36 antigens
has been described previously (Salazar-Anton and Lindh
2011). In short, the genes corresponding to the Tsol-p27 and
TsolHSP36 antigens were inserted into the plasmid vector
pGEX-4T-1 (Amersham Pharmacia) downstream of glutathi-
one S-transferase (GST). Both recombinant proteins were
expressed in Escherichia coli BL21 (Invitrogen) and purified.
In addition to the purification step with glutathione-agarose
beads, Tsol-p27 antigen was furtherpurified using his-selected
nickel magnetic beads (Sigma). The resin was equilibrated
with a buffer containing 50 mM sodium phosphate (pH 8.0),
0.3M sodium chloride, and10mM imidazole,and then eluted
with a higher concentration of imidazole (250 mM). The
histidine-containing proteins were separated from the fraction
by applying a magnetic separator to the mixed solution. The
antigen purity was analyzed by 10% SDS PAGE and visual-
ized by staining with Coomassie Brilliant Blue.
EITB (commercial)
EITB was performed according to the procedure recommen-
ded by the manufacturer (LDBIO Diagnostic, Lyon, France).
Antibody-detection ELISA (commercial)
A commercial ELISA was used according to the manufac-
turer’s instructions (Cypress Diagnostics). This test detected
the presence of IgG antibodies against T. solium cysticerci in
serum samples. A spectrophotometer (450 nm) was used to
obtain optical density reading. Various controls were used
for the validity of the ELISA including antibody blank,
negative control serum, and positive control serum. The
reaction threshold was 0.600. Values ≥0.600 were consid-
ered positive for cysticercosis.
Western blot analysis of Tsol-p27 and TsolHSP36 antigens
(in house)
The recombinant antigens were separated by 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred onto nitrocellulose membranes (GE
2188 Parasitol Res (2012) 110:2187–2191Healthcare). A positive sample was recorded if a band could
be seen at 27 kDA in the Western blot Tsol-p27 and at
36 kDa in the Western blot TsolHSP36. The membranes
were blocked for 2 h with 5% skim milk in phosphate-
buffered saline (PBS, pH 7.5) and then rinsed in washing
buffer containing PBS and 0.05% Tween 20. Thereafter, the
membranes were incubated first for 3 h with human sera
diluted 1:500 in 5% skim milk–PBS, and then for 1 h with
rabbit anti-human IgG conjugated with peroxidase (Sigma)
diluted 1:3000 in 5% skim milk–PBS. The subsequent
washing steps and detection procedures were performed
according to the ECL Plus manual (GE Healthcare).
Immunodot blot analysis of Tsol-p27 (in house)
Immunodot blot analysis was carried out using a nitrocellulose
membrane (GE Healthcare), which was pre-wetted with dis-
tilled water and then placed into a bio-dot blot apparatus (Bio-
Rad, Hercules, CA, USA). This was followed by fixation of
10 μg of recombinant Tsol-p 27 protein that had been purified
using glutathione agarose and his-selected nickel beads. The
apparatus was left at room temperature for 1 h to allow antigen
immobilization. The dots were subsequently blocked for 1 h
with 5% skim milk in PBS containing 0.05% Tween 20 and
thenwashedthreetimeswithPBScontaining0.05% Tween20.
Thereafter, the dots were incubated for 4 h with human sera
diluted 1:1000 in 5% skim milk–PBS and washed three times
with PBS containing 0.05% Tween 20, and this was followed
byaddition of 100 μl of rabbit anti-human IgG conjugated with
peroxidase (Sigma) diluted 1:4000 in 5% skim milk–PBS. The
subsequent washing steps and detection procedures were per-
formedaccordingtotheECLPlusmanual(GEHealthcare).All
analyses of the serum samples were performed in duplicate.
Results
To increase the efficacy and reduce the background of the in
house immunodot blot method, the Tsol-p27 protein was
purified using his-selected nickel magnetic agarose and
glutathione-agarose beads. Figure 1 shows the Tsol-p27
antigen in a 10% SDS-PAGE, visualized by staining with
Coomassie Brilliant Blue.
The sensitivity and specificity values were determined
based on the positive and negative results for Tsol-p27
antigen obtained by commercial EITB analysis, the gold
standard method. Of the 100 investigated serum samples
from epileptic patients, 13 were positive and 87 negative by
EITB. The same number of serum samples was analyzed
using immunodot blot Tsol-p27, and an example of the
results for sera from epileptic patients and patients with
positive and negative serology to Chagas diseases is pre-
sented in Fig. 2. Corresponding results obtained by the
commercial ELISA and in house Western blot Tsol-p27/
TsolHSP36 are shown (Tables S1 and S2 in the Electronic
supplementary material). Table 1 summarizes the perfor-
mance of the different immunodiagnostic tests compared
to the gold standard method EITB for detection of anti-
bodies in serum from epileptic human subjects.
The immunodot blot Tsol-p27 was found to offer 86.7%
sensitivity and 97.8% specificity, with a positive predictive
value (PPV) of 86.7% and a negative predictive value
(NPV) of 97.8%. Corresponding values for the other tests
were as follows: ELISA, 86.7% sensitivity and 94.6% spec-
ificity (PPV 72.2%, NPV 97.8%); Western blot Tsol-p27,
76.4% sensitivity and 95.6% specificity (PPV 76.5%, NPV
98.9%); Western blot TsolHSP36, 61.9% sensitivity and
86.1% specificity (PPV 48.1%, NPV 91.5%, Table 2).
Discussion
Immunodiagnosis of human cysticercosis has been accom-
plished using a variety of methods, including indirect hem-
agglutination tests, ELISA, indirect fluorescent antibody
tests, radioimmunoassay, complement fixation assays, im-
munoelectrophoresis, dot blot, and EITB (Deckers and
Fig. 1 SDS-PAGE analysis of Tsol-p27 antigen. Lane 1, cells from
induced E. coli; lane 2, purified recombinant GST/Tsol-p27; lane 3,
Tsol-p27 digested with precision protease; lane 4, Tsol-p27 after puri-
fication using glutathione-agarose and his-selected nickel magnetic
beads
Fig. 2 Immunodot blot using the Tsol-p27 antigen. a Probing done
with two positive serum controls (A1–A2) followed by sera from seven
positive epileptic cases (A3–A9) and two negative serum controls
(A10–A11). b, c Probing done with negative serum samples from
epileptic cases (b), and with sera from patients with positive (1–6) or
negative (7–11) serology for Chagas disease (c)
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et al. 1995). The most specific test developed thus far is
EITB, with reported specificity of 100% and sensitivity of
98%. However, the sensitivity of this test drops considerably
in cases involving single cysts in the brain (Singh et al.
1999). The EITB method uses an enriched fraction of gly-
coproteins prepared by lectin-affinity purification from an
extract of intact cysticerci (Deckers and Dorny 2010; Tsang
et al. 1989). Some of the drawbacks of EITB are that it
requires sophisticated equipment and trained personnel to
perform the test, it is not suitable for field studies, and it is
seldom affordable in countries where cysticercosis is en-
demic (Deckers and Dorny 2010; Dorny et al. 2003). There-
fore, research projects have been focused on developing
new serological diagnostic tools that offer sensitivity and
specificity, and are easy to perform in poorly equipped
laboratories. The aim of the present study was to study the
efficacy of an immunodot blot using the Tsol-p27 protein
(immunodot blot Tsol-p27) in comparison with various
immunodiganostic formats and antigens. More specifically,
a commercial ELISA and the antigens TsolHSP36 and Tsol-
p27 in Western blot formats (Western blot Tsol-p27/
TsolHSP36) were included in the serological evaluation.
The Tsol-p27 antigen was efficiently expressed in E. coli
as a fusion protein with his and GST fusion parts, and it was
purified in two steps using glutathione-agarose and his-
selected nickel beads. Our immunodot blot technique used
a highly purified Tsol-p27 antigen, which decreased the
background (e.g., E. coli antigen) seen in Western blot
analysis using one-step purified Tsol-p27 antigen (Fig. 1,
lane 3). The EITB results were considered confirmatory of
human cysticercosis and were used as a standard to assess
the performance of the different diagnostic methods. A total
of 100 human serum samples from epileptic patients were
examined by EITB, and antibodies to T. solium cysticercus
were detected in 13 of those samples.
In our study, immunodot blot Tsol-p27 was comparable to
Western blot Tsol-p27 with regard to specificity (97.8% vs.
95.6%) but not sensitivity (86.7% vs. 76.4%), and it was
similar to ELISA regarding both specificity (97.8% vs.
94.6%) and sensitivity (86.7% vs. 86.7%). Western blot-
TsolHSP36 showed lower specificity (86.1%) and sensitivity
(61.9%) compared to the other immunodiagnostic methods. It
has previously been noted that the Tsol-p27 antigen has po-
tentialfordiagnosisofhumancysticercosis.Inanearlierstudy
(Salazar-Anton and Lindh 2011), Western blot showed that
antibodiesinserumfromNCCpatients,butnotthoseinserum
from a control group, could identify the Tsol-p27 antigen.
Furthermore, it has been reported that using ELISA to detect
specific antibodies against T. solium cysticerci in samples
from patients with suspected cysticercosis provides a useful
tool for diagnosing this disease in humans (Rosas et al. 1986;
Simac et al. 1995). However, the results of ELISA used for
this purpose vary significantly (Bucardo et al. 2005; Carpio
1998),andthediscrepanciesbetweenstudiescanbeexplained
by the use of disparate criteria for patient selection and differ-
ent methods as the gold standard. In our investigation, West-
ern blot TsolHSP36 offered lower sensitivity and specificity
compared to immunodot blot Tsolp-27, Western blot Tsol-
p27, and the commercial ELISA. Notably, the TsolHSP36
antigen has previously been described as an antigenic target
in the diagnosis of human cysticercosis (Ferrer et al. 2005).
We also used immunodot blot Tsol p-27 to analyze serum
samples from patients with positive or negative serology for
Chagas disease, and none of those sera recognized the Tsol-
p27 antigen. There is an overlap in the epidemiology of
Table 1 Comparison of different immunodiagnostic tests with EITB
as the gold standard method for detection of antibodies against T.




Positive 13 5 18
Negative 2 87 89
Total 15 92 102
Commercial ELISA
Positive 13 5 18
Negative 2 87 89
Total 15 92 102
Western blot Tsol-p27
Positive 13 4 17
Negative 1 87 88
Total 14 91 105
Western blot TsolHSP36
Positive 13 14 27
Negative 8 87 95
Total 21 101 122
Table 2 Sensitivity, specificity,
and PPVand NPV values of
the immunodiagnostic tests used
to diagnose T. solium
cysticerci in serum samples from
epileptic patients
Immunodiagnostic test Sensitivity Specificity PPV NPV
Immunodot blot Tsol-p27 86.7% 97.8% 86.7% 97.8%
Commercial ELISA 86.7% 94.6% 72.2% 97.8%
Western blot Tsol-p27 76.4% 95.6% 76.5% 98.9%
Western blot TsolHSP36 61.9% 86.1% 48.1% 91.5%
2190 Parasitol Res (2012) 110:2187–2191Chagas disease and human cysticercosis, both of which are
considered to be neglected tropical illnesses and occur in
poor rural communities of low-income countries in Latin
America (Bethony et al. 2011).
At present, T. solium antigens for diagnosis of human
cysticercosis are derived from parasites extracted from
infected pork (Deckers and Dorny 2010). Perhaps recombi-
nant antigens can serve as a simplified, low-cost substitute
for the native antigens, and also provide a reproducible,
field-applicable diagnostic assay (Scheel et al. 2005). The
immunodot blot Tsol-p27 test showed good sensitivity and
specificity in our study, and it is simpler to perform and less
expensive than ELISA, EITB, and Western blot. Moreover,
immunodot blot Tsol-p27 does not require a spectrophotom-
eter to read the results or electrophoresis and transfer equip-
ment to absorb the antigen onto nitrocellulose membranes
(Plancarte et al. 1994). It is plausible that this test will prove
to be the serodiagnostic method of choice for use in the field
or in poorly equipped laboratories in endemic countries.
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